Page 97 - Sách năm 2022 - Fulltext - hieu final

28. Leisman, D.E., et al., Survival Benefit and Cost Savings From Compliance With a Simplified 3-Hour
Sepsis Bundle in a Series of Prospective, Multisite, Observational Cohorts. Crit Care Med, 2017. 45(3): p.
395-406.
29. Levy, M.M., et al., The Surviving Sepsis Campaign: results of an international guideline-based
performance improvement program targeting severe sepsis. Crit Care Med, 2010. 38(2): p. 367-74.
30. Levy, M.M., et al., The Surviving Sepsis Campaign: results of an international guideline-based
performance improvement program targeting severe sepsis. Intensive Care Med, 2010. 36(2): p. 222-31.
31. Levy, M.M., et al., Sepsis change bundles: converting guidelines into meaningful change in behavior
and clinical outcome. Crit Care Med, 2004. 32(11 Suppl): p. S595-7.
32. Levy, M.M., et al., Surviving Sepsis Campaign: association between performance metrics and outcomes
in a 7.5-year study. Intensive Care Medicine, 2014. 40(11): p. 1623-1633.
33. Levy, M.M., et al., Surviving Sepsis Campaign: association between performance metrics and outcomes
in a 7.5-year study. Crit Care Med, 2015. 43(1): p. 3-12.
34. Liu, V.X., et al., Multicenter Implementation of a Treatment Bundle for Patients with Sepsis and
Intermediate Lactate Values. Am J Respir Crit Care Med, 2016. 193(11): p. 1264-70.
35. Martin, G., Sepsis, severe sepsis and septic shock: Changes in incidence, pathogens and outcomes.
Expert review of anti-infective therapy, 2012. 10: p. 701-6.
36. Mayr, F.B., S. Yende, and D.C. Angus, Epidemiology of severe sepsis. Virulence, 2014. 5(1): p. 4-11.
37. Mitchell, K.H., et al., Volume Overload: Prevalence, Risk Factors, and Functional Outcome in Survivors
of Septic Shock. Ann Am Thorac Soc, 2015. 12(12): p. 1837-44.
38. Osborn, T.M., H.B. Nguyen, and E.P. Rivers, Emergency medicine and the surviving sepsis campaign:
an international approach to managing severe sepsis and septic shock. Ann Emerg Med, 2005. 46(3): p.
228-31.
39. Patel, J.J., et al., The association of serum bilirubin levels on the outcomes of severe sepsis. J Intensive
Care Med, 2015. 30(1): p. 23-9.
40. Paul, M., et al., Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic
therapy for sepsis. Antimicrob Agents Chemother, 2010. 54(11): p. 4851-63.
41. Phua, J., et al., Management of severe sepsis in patients admitted to Asian intensive care units:
prospective cohort study. Bmj, 2011. 342: p. d3245.
42. Rhodes, A., et al., The Surviving Sepsis Campaign bundles and outcome: results from the International
Multicentre Prevalence Study on Sepsis (the IMPreSS study). Intensive Care Med, 2015. 41(9): p. 1620-8.
43. Rodríguez, F., et al., The epidemiology of sepsis in Colombia: a prospective multicenter cohort study in
ten university hospitals. Crit Care Med, 2011. 39(7): p. 1675-82.
44. Services, C.M.M. CMS to Improve Quality of Care duringHospitalInpatientStays,. 2014; Available
from: https://www.cms.gov/Newsroom/MediaReleaseDatabase/Factsheets/2014-Fact-sheets-items/2014-
08-04-2.html.
45. Seymour, C., et al., Time to Treatment and Mortality during Mandated Emergency Care for Sepsis. The
New England journal of medicine, 2017. 376.
46. Seymour, C.W., et al., Time to Treatment and Mortality during Mandated Emergency Care for Sepsis.
New England Journal of Medicine, 2017. 376(23): p. 2235-2244.
47. Shapiro, N.I., et al., Serum lactate as a predictor of mortality in emergency department patients with
infection. Ann Emerg Med, 2005. 45(5): p. 524-8.
48. Sousa, A., et al., The impact of each action in the Surviving Sepsis Campaign measures on hospital
mortality of patients with severe sepsis/septic shock. Einstein, 2008. 6.
49. Zadroga, R., et al., Comparison of 2 blood culture media shows significant differences in bacterial
recovery for patients on antimicrobial therapy. Clin Infect Dis, 2013. 56(6): p. 790-7.
50. Zhou, J., et al., Epidemiology and outcome of severe sepsis and septic shock in intensive care units in
mainland China. PLoS One, 2014. 9(9): p. e107181.

97